ArticleJournal of Cancer2024

Administering immunotherapy after anti-vascular targeted therapy improves overall survival of patients with metastatic clear cell renal cell carcinoma.

Zhiwei Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.